Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Probenecid and cilastatin reduce cardiac fibrosis and myocyte hypertrophy ex vivo

Aug. 18, 2010

Briakinumab is safe and efficacious in phase II and III trials in psoriasis

Aug. 17, 2010

LIPO-102 reduces abdominal fat in phase IIa study

Aug. 17, 2010

Riluzole exhibits cardioprotective activity in vivo

Aug. 17, 2010

FT-23 attenuates diastolic dysfunction in model of diabetic cardiomyopathy

Aug. 16, 2010

Iontophoretically delivered terbinafine enters phase II trial in onychomycosis

Aug. 16, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

Onabotulinumtoxin A is safe and efficacious in women with vertical lip columns

Aug. 13, 2010

New clindamycin/tretinoin gel more effective than constituents in treating acne

Aug. 13, 2010

Cannabinoids show promise in models of inflammation and bone loss

Aug. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...